Stocks Comparison
Cryo Cell International vs Davita: revenue, profit, margins and growth compared
Cryo Cell International brought in $31.6M of revenue in fiscal 2025, Davita $13.6B in fiscal 2025. Revenue changed by -1.3% at Cryo Cell International and +6.5% at Davita on the year before, so Davita grew faster. Cryo Cell International kept -7.7% of its revenue as net profit, Davita 5.5%. Free cash flow was $5.2M at Cryo Cell International and $1.3B at Davita.
Side by side, latest fiscal year
| CCEL | DVA | |
|---|---|---|
| Fiscal year ended | FY2025 (November 30, 2025) | FY2025 (December 31, 2025) |
| Revenue | $31.6M | $13.6B |
| Revenue growth | -1.3% | +6.5% |
| Net income | -$2.4M | $746.8M |
| Net margin | -7.7% | 5.5% |
| Free cash flow | $5.2M | $1.3B |
| Free cash flow margin | 16.6% | 9.6% |
| Earnings per share (diluted) | -$0.30 | $9.84 |
| Cash | $319K | $676.4M |
| Debt | $8.4M | $10.3B |
| Price to earnings | n/a | 18.1 |
| Market value | $34.2M | $11.4B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #412 of 646 · Health care | #37 of 646 · Health care |
Over the years
Questions about Cryo Cell International and Davita
Which is bigger by revenue, Cryo Cell International or Davita?
Davita is bigger by revenue: $13.6B in fiscal 2025, against $31.6M for Cryo Cell International in fiscal 2025.
Which keeps more of its revenue as profit, Cryo Cell International or Davita?
Cryo Cell International had a net margin of -7.7% in fiscal 2025; Davita had 5.5% in fiscal 2025.
Which grew revenue faster, Cryo Cell International or Davita?
In their latest fiscal years revenue changed by -1.3% at Cryo Cell International and +6.5% at Davita.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.